LINC02255

Across TCGA pan-cancer cohorts, LINC02255 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02255 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher LINC02255 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02255 expression acts as an unfavorable survival marker, although some lineages such as HNSC and THCA show a favorable association.

TGCT, SKCM, and BRCA are the cancer types where LINC02255 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	108	view →
SKCM	OS	Tertile	II,III,IV	0.752	0.858	.006	45	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
MESO	OS	Quartile	All	0.200	0.657	.001	29	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.765	.001	27	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	27	view →
UCS	OS	Tertile	IV	0.253	0.691	.022	18	view →
ACC	DFS	Tertile	II,III,IV	0.242	0.724	.034	18	view →
HNSC	DFS	Median	All	0.384	0.278	.008	15	view →
THCA	DFS	Tertile	All	0.962	0.809	.036	12	view →
KIRC	DFS	Tertile	III,IV	0.351	0.512	.021	10	view →
KICH	DFS	Tertile	All	0.521	0.906	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC02255–TGCT (OS)

Open the TGCT breakdown →